CURRENT STUDENTS
The Pharmacology and Molecular Medicine Training Program currently has 31 students enrolled in the PhD Program. Of the current students, 2 entered the program as MD/PhD (MSTP) students; and 7 others entered the program from the umbrella Biomedical Science Program (BSP). The Pharmacology Graduate Training Program consistently matriculates students from all three potential sources: direct recruiting, the BSP, and the MSTP.
Over the last ten years, the average size of the matriculated class of Pharmacology and Molecular Medicine Training Program students has been 4.6 and the average time to degree is ~5.7 years. The retention rate, that is students who complete the program with their PhD is 100% over the last 10 years. Another 5 students completed the program with MS degrees. Thus, the overall percentage of a students graduating with an advanced degree is (51/59) 95%.
| First-Year Cohort | Student Name, Degree, and Undergraduate Institution |
Madison Cho-Richmond | |
Danielle Heebner | |
Rachel Stander | |
Jordan Swartz |
| Second-Year Cohort | Student Name, Degree, and Undergraduate Institution |
 | Brian Brady BS, Psychology, Pennsylvania State Univ., University Park, PA MS, Molecular Neuroscience, University of Bristol Mentor: Kennedy, Matthew Investigating the disruption of excitatory synaptic nanoscale architecture. |
 | Shelby Fainelli BS, Cell and Molecular Neuroscience, Colorado State University, Fort Collins, CO Mentor: Aoto, Jason Characterizing the binding partners of the presynaptic cell adhesion molecule, Neurexin 1. |
 | Patrick Pence Mentor: Investigating SEMA7A CAR T cells with T cell backpacks to improve TNBC tumor treatment. |
 | Heidi Solis BS, Biological Science, California State University, Sacramento, CA Mentor: Jacobelli, Jordan Exploring the mechanistic role of formin cytoskeletal proteins on lymphocyte migration |
 | Annalise Sturno BA, Biology and Cognitive Science, Case Western Reserve University, Cleveland, OH Mentor: Bruce, Kimberly Investigating the role of GLUT5 fructose transporter in microglial metabolic reprogramming in Alzheimer's disease. |
 | Raul Vargas BS, Neuroscience, University of Cincinnati, Cincinnati, OH Mentor: Oh, Won Chan Investigating Serotonergic Psychedelics in Inhibitory Plasticity.
|
| Third-Year Cohort | Student Name, Degree, and Undergraduate Institution |
 | Madison Barker BS, Biochemistry, University of Colorado, Denver, CO Mentor: Bayer, Ulli Exploring CaMKII's role in synaptic plasticity, structure-function relationships, and its therapeutic potential for diseases. |
 | Ralf Dagdag BS, University of Alaska, Anchorage, 2016; MS, University of Alaska, Anchorage, AK Mentor: Gixnoux, Chris R and Costello, James Elucidating the causal relationship between germline and somatic mutations in prostate cancer aggression |
 | Selin Ekici BS, Chemistry, Emory University, Atlanta, GA Mentor: Ford, Chris Mechanism of action of antipsychotics at the D2 receptor |
 | Hannah Ferris BA, Biochemistry, Hamilton College, Clinton, NY, 2016; MS., Medical Science, University of Vermont, Burlington, VT Mentor: Dabertrand, Fabrice Elucidating the molecular basis for cerebral microvasculature dysfunction |
 | Phinea Romero BS, Neurobiology, Psychology, University of Wisconsin, Madison, Madison, WI Mentor: Dabertrand, Fabrice Investigating the role of the cerebral microvasculature in neurodevelopmental and neuropsychiatric disorders |
.png?sfvrsn=664578bb_0 "Cailin Deiter")
